Aurobindo Pharma acquires branded non-oncology prescription business of Khandelwal Labs’ for Rs 325 crore

HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd on a going concern, slump sale basis for a cash consideration of Rs 325 crore in a move aimed at strengthening its presence in the domestic formulations market.The […]